Atlas Trials

Efficacy and Safety of Shenyankangfu Tablets for Primary Glomerulonephritis

Clinical trial NCT02063100 · UNKNOWN

Trial details

NCT number
NCT02063100
Sponsor
Chinese PLA General Hospital
Status
UNKNOWN
Phase
Phase 4
Study type
INTERVENTIONAL
GlomerulonephritisProteinuria
Start date
2014-02-01
Primary completion
2015-07-01
Enrollment
720

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.